Author Index to Vol. 19

European Journal of Pharmaceutical Sciences, 19 (2003) 461–463 www.elsevier.com / locate / ejps

Author Index, Volume 19 Agersø, H. and P. Vicini, Pharmacodynamics of NN2211, a novel long acting GLP-1 derivative (19) 141 ˚ Tunon ´ (19) 333 Alderborn, G., see A. Alkhamis, K.A., see H. Allaboun (19) 231 Allaboun, H., K.A. Alkhamis and W.Y. AlMomani, The application of the convective diffusion model and the film equilibrium model to surfactant-facilitated dissolution of gliclazide (19) 231 AlMomani, W.Y., see H. Allaboun (19) 231 ¨ Amon, A., see E. Goßnitzer (19) 151 Arashiki, Y., see H. Saitoh (19) 133 Arnaud, P., see H. Marchais (19) 129 Artursson, P., see H. Engman (19) 57 ¨ ¨ Asunmaa, K., see H. Monkkonen (19) 23 ¨ ¨ Auriola, S., see H. Monkkonen (19) 23 Bajad, S., M. Coumar, R. Khajuria, O.P. Suri and K.L. Bedi, Characterization of a new rat urinary metabolite of piperine by LC / NMR / MS studies (19) 413 Baudet, G., see M. Bizi (19) 373 Bauer-Brandl, A., see G.L. Perlovich (19) 423 Bedi, K.L., see S. Bajad (19) 413 Behrens, I. and T. Kissel, Do cell culture conditions influence the carrier-mediated transport of peptides in Caco-2 cell monolayers? (19) 433 Berridge, T., see R.D. Combes (19) 1 Bhaskar, P., see Y.S.R. Krishnaiah (19) 355 Bizi, M., M.P. Flament, P. Leterme, G. Baudet and A. Gayot, Relation between structural characteristics of talc and its properties as an antisticking agent in the production of tablets (19) 373 Burgot, J.L., see G. Dollo (19) 273 Calpena, A.C., see E. Escribano (19) 203 Castelli, F., M. Grazia Sarpietro, C. Messina, A. De Lazzari, D. Di Rosa and A. Giannetto, Differential scanning calorimetry differences in micronized and unmicronized nimesulide uptake processes in biomembrane models (19) 237 Cayzeele, G., see H. Marchais (19) 129 Chang, J.-S., see P.-C. Wu (19) 115 Chemtob, C., see P. Mura (19) 67 Cheng, H.-C., see J.-Y. Fang (19) 253 Cheong, W.S., see P.W.S. Heng (19) 381 Chevanne, F., see G. Dollo (19) 273 Chou, C.C., S.L. Pan, C.M. Teng and J.H. Guh, Pharmacological evaluation of several major ingredients of Chinese herbal medicines in human hepatoma Hep3B cells (19) 403 Christensen, J.D., see L. Moesby (19) 245 Christiansen, L., see A. von Bonsdorff-Nikander (19) 173 Combes, R.D., T. Berridge, J. Connelly, M.D. Eve, R.C. Garner, S. Toon and P. Wilcox, Early microdose drug studies in human volunteers can minimise animal testing: Proceedings of a workshop organised by Volunteers in Research and Testing (19) 1 Connelly, J., see R.D. Combes (19) 1 Cornett, C., see H. Parshad (19) 263 Coumar, M., see S. Bajad (19) 413

doi:10.1016 / S0928-0987( 03 )00189-1

Danhof, M., see M.P. Schaddelee (19) 13 David, C.J., see M.M. Victoria (19) 123 de Boer, A.G., see M.P. Schaddelee (19) 13 De Lazzari, A., see F. Castelli (19) 237 Di Rosa, D., see F. Castelli (19) 237 Dinesh Kumar, B., see Y.S.R. Krishnaiah (19) 355 ´ Dollo, G., P. Le Corre, A. Guerin, F. Chevanne, J.L. Burgot and R. Leverge, Spray-dried redispersible oil-in-water emulsion to improve oral bioavailability of poorly soluble drugs (19) 273 ´ Domenech, J., see E. Escribano (19) 203 ¨ EnantioselecEngman, H., C. Tannergren, P. Artursson and H. Lennernas, tive transport and CYP3A4-mediated metabolism of R / S-verapamil in Caco-2 cell monolayers (19) 57 Ertan, G., see E. Karasulu (19) 99 ´ Escribano, E., A.C. Calpena, J. Queralt, R. Obach and J. Domenech, Assessment of diclofenac permeation with different formulations: anti-inflammatory study of a selected formula (19) 203 Eskandar, F., see H. Steckel (19) 443 Eve, M.D., see R.D. Combes (19) 1 Fang, J.-Y., Y.-L. Leu, T.-L. Hwang, H.-C. Cheng and C.-F. Hung, Development of sesquiterpenes from Alpinia oxyphylla as novel skin permeation enhancers (19) 253 ¨ Favre, B., see E. Goßnitzer (19) 151 Flament, M.P., see M. Bizi (19) 373 Freitag, F. and P. Kleinebudde, How do roll compaction / dry granulation affect the tableting behaviour of inorganic materials? Comparison of four magnesium carbonates (19) 281 Frydenvang, K., see H. Parshad (19) 263 Garner, R.C., see R.D. Combes (19) 1 ˇ Gasperlin, M., see J. Kristl (19) 181 Gayot, A., see M. Bizi (19) 373 Giannetto, A., see F. Castelli (19) 237 ¨ Goßnitzer, E., A. Punkenhofer, A. Amon and B. Favre, Novel high energy intermediate analogues with triazasterol-related structures as inhibitors of ergosterol biosynthesis. III. Synthesis and antifungal activity of N 4 -alkyl-1,6,7,11b-tetrahydro-2H-pyrimido[4,3a]isoquinolin-4-amine salts (19) 151 Grazia Sarpietro, M., see F. Castelli (19) 237 ˚ Tunon ˚ ¨ J., see A. ´ (19) 333 Grasjo, ´ Guerin, A., see G. Dollo (19) 273 Guh, J.H., see C.C. Chou (19) 403 ¨ Guneri, T., see E. Karasulu (19) 99 Gupta, R.C., see M. Issar (19) 105 Hansen, E.W., see L. Moesby (19) 245 Hatakeyama, Y., see H. Saitoh (19) 133 ¨ T., see L. Peltonen (19) 395 Heikkila, Heng, P.W.S., T.W. Wong and W.S. Cheong, Investigation of melt agglomeration process with a hydrophobic binder in combination with sucrose stearate (19) 381 Hirvonen, J., see L. Peltonen (19) 395

462

Author Index, Volume 19 (2003) 461 – 463

¨ Hoglund, P., see J. Mercke Odeberg (19) 299 Hosoi, K., see H. Saitoh (19) 133 Huang, Y.-B., see P.-C. Wu (19) 115 Hung, C.-F., see J.-Y. Fang (19) 253 Huuskonen, J., see J. Juntunen (19) 37 Hwang, T.-L., see J.-Y. Fang (19) 253 Ijzerman, A.P., see M.P. Schaddelee (19) 13 Issar, M., S.K. Singh, B. Mishra and R.C. Gupta, Pharmacokinetics, in-situ absorption and protein binding studies of a new neuroleptic agent centbutindole in rats (19) 105 ¨ Jappinen, A., M. Turpeinen, H. Kokki, A. Rasi, T. Ojanen, O. Pelkonen and T. Naaranlahti, Stability of sufentanil and levobupivacaine solutions and a mixture in a 0.9% sodium chloride infusion stored in polypropylene syringes (19) 31 ¨ Jarvinen, T., see J. Juntunen (19) 37 Juntunen, J., J. Huuskonen, K. Laine, R. Niemi, H. Taipale, T. ¨ Nevalainen, D.W. Pate and T. Jarvinen, Anandamide prodrugs. 1. Water-soluble phosphate esters of arachidonylethanolamide and Rmethanandamide (19) 37 ¨ ¨ Jurjenson, H., see M. Sakkinen (19) 345 ˇ P., see J. Kristl (19) 181 Jurkovic, Karalis, V. and P. Macheras, Pharmacodynamic considerations in bioequivalence assessment: comparison of novel and existing metrics (19) 45 ¨ Karasulu, E., H. Yes¸im Karasulu, G. Ertan, L. Kirilmaz and T. Guneri, Extended release lipophilic indomethacin microspheres: formulation factors and mathematical equations fitted drug release rates (19) 99 Karjalainen, M., see A. von Bonsdorff-Nikander (19) 173 Karthikeyan, R.S., see Y.S.R. Krishnaiah (19) 355 Khajuria, R., see S. Bajad (19) 413 Khalili, P., E. Naimi, W.Y. Sun, E.E. Knaus and L.I. Wiebe, Biochemical and pharmacokinetic evaluation of a novel pyrimidine nucleoside nitric oxide donor as a potential anticancer / antiviral agent (19) 305 Kirilmaz, L., see E. Karasulu (19) 99 Kissel, T., see I. Behrens (19) 433 Kleinebudde, P., see F. Freitag (19) 281 Knaus, E.E., see P. Khalili (19) 305 Kobayashi, M., see H. Saitoh (19) 133 ¨ Kokki, H., see A. Jappinen (19) 31 Kontturi, K., see L. Peltonen (19) 395 Krishnaiah, Y.S.R., V. Satyanarayana, B. Dinesh Kumar, R.S. Karthikeyan and P. Bhaskar, In vivo pharmacokinetics in human volunteers: oral administered guar gum-based colon-targeted 5-fluorouracil tablets (19) 355 ˇ ˇ ˇ Effect of Kristl, J., B. Volk, M. Gasperlin, M. Sentjurc and P. Jurkovic, colloidal carriers on ascorbyl palmitate stability (19) 181 Kurkov, S.V., see G.L. Perlovich (19) 423 Laine, K., see J. Juntunen (19) 37 Larhrib, H., G.P. Martin, D. Prime and C. Marriott, Characterisation and deposition studies of engineered lactose crystals with potential for use as a carrier for aerosolised salbutamol sulfate from dry powder inhalers (19) 211 Larsen, C., see H. Parshad (19) 263 Le Corre, P., see G. Dollo (19) 273 Legendre, J.-Y., see H. Marchais (19) 129 Lehto, V.-P., see M. Tarvainen (19) 363 ¨ H., see H. Engman (19) 57 Lennernas, Leterme, P., see M. Bizi (19) 373 Leu, Y.-L., see J.-Y. Fang (19) 253 Leverge, R., see G. Dollo (19) 273 ˚ see J. Mercke Odeberg (19) 299 Lignell, A., Liljefors, T., see H. Parshad (19) 263 Liljeroth, P., see L. Peltonen (19) 395

Macheras, P., see V. Karalis (19) 45 Maestrelli, F., see P. Mura (19) 67 Marchais, H., G. Cayzeele, J.-Y. Legendre, M. Skiba and P. Arnaud, Cross-linking of hard gelatin carbamazepine capsules: effect of dissolution conditions on in vitro drug release (19) 129 Marriott, C., see H. Larhrib (19) 211 Martin, G.P., see H. Larhrib (19) 211 ¨ Marvola, M., see M. Sakkinen (19) 345 Maunus, J., see M. Tarvainen (19) 363 Mennini, N., see P. Mura (19) 67 ˚ Lignell, A. Pettersson and P. Hoglund, ¨ Mercke Odeberg, J., A. Oral bioavailability of the antioxidant astaxanthin in humans is enhanced by incorporation of lipid based formulations (19) 299 Messina, C., see F. Castelli (19) 237 Middaugh, C.R., see W. Tiyaboonchai (19) 191 Mikkonen, H., see M. Tarvainen (19) 363 Mishra, B., see M. Issar (19) 105 Moesby, L., E.W. Hansen, J.D. Christensen, L. Tommerup and C. Nielsen, Endospores of B. subtilis are pyrogenic and activate Mono Mac 6 cells: importance of the CD14 receptor (19) 245 ¨ ¨ ¨ ¨ Monkkonen, H., S. Tormalehto, K. Asunmaa, R. Niemi, S. Auriola, J. ¨¨ ¨ ¨ Vepsalainen and J. Monkkonen, Cellular uptake and metabolism of clodronate and its derivatives in Caco-2 cells: a possible correlation with bisphosphonate-induced gastrointestinal side-effects (19) 23 ¨ ¨ ¨ ¨ (19) 223 Monkkonen, J., see A. Toyras ¨ ¨ ¨ ¨ Monkkonen, J., see H. Monkkonen (19) 23 Mura, P., N. Zerrouk, N. Mennini, F. Maestrelli and C. Chemtob, Development and characterization of naproxen–chitosan solid systems with improved drug dissolution properties (19) 67 ¨ Naaranlahti, T., see A. Jappinen (19) 31 Naimi, E., see P. Khalili (19) 305 Nevalainen, T., see J. Juntunen (19) 37 Nielsen, C., see L. Moesby (19) 245 ¨ ¨ Niemi, R., see H. Monkkonen (19) 23 Niemi, R., see J. Juntunen (19) 37 Obach, R., see E. Escribano (19) 203 Oda, M., see H. Saitoh (19) 133 ¨ Ojanen, T., see A. Jappinen (19) 31 Oka, A., see H. Saitoh (19) 133 ¨ ¨ (19) 223 Ollikainen, J., see A. Toyras Pan, S.L., see C.C. Chou (19) 403 Paronen, P., see M. Tarvainen (19) 363 Parshad, H., K. Frydenvang, T. Liljefors, C. Cornett and C. Larsen, Assessment of drug salt release from solutions, suspensions and in situ suspensions using a rotating dialysis cell (19) 263 Pate, D.W., see J. Juntunen (19) 37 Pateman, T.J., see M.P. Schaddelee (19) 13 ¨ Pelkonen, O., see A. Jappinen (19) 31 ¨ K. Kontturi and J. Hirvonen, Peltonen, L., P. Liljeroth, T. Heikkila, Dissolution testing of acetylsalicylic acid by a channel flow method— correlation to USP basket and intrinsic dissolution methods (19) 395 Peltonen, S., see M. Tarvainen (19) 363 Perlovich, G.L., S.V. Kurkov and A. Bauer-Brandl, Thermodynamics of solutions. II. Flurbiprofen and diflunisal as models for studying solvation of drug substances (19) 423 Pettersson, A., see J. Mercke Odeberg (19) 299 Prime, D., see H. Larhrib (19) 211 ¨ Punkenhofer, A., see E. Goßnitzer (19) 151 Queralt, J., see E. Escribano (19) 203 Qureshi, S.A. and J. Shabnam, Applications of a new device (spindle) for improved characterization of drug release (dissolution) of pharmaceutical products (19) 291 Rantanen, J., see A. von Bonsdorff-Nikander (19) 173

Author Index, Volume 19 (2003) 461 – 463 ¨ Rasi, A., see A. Jappinen (19) 31 Saitoh, H., Y. Arashiki, A. Oka, M. Oda, Y. Hatakeyama, M. Kobayashi and K. Hosoi, Arbekacin is actively secreted in the rat intestine via a different efflux system from P-glycoprotein (19) 133 ¨ ¨ Sakkinen, M., T. Tuononen, H. Jurjenson, P. Veski and M. Marvola, Evaluation of microcrystalline chitosans for gastro-retentive drug delivery (19) 345 Sato, J., see K. Watanabe (19) 91 Satyanarayana, V., see Y.S.R. Krishnaiah (19) 355 Schaddelee, M.P., H.L. Voorwinden, E.W. van Tilburg, T.J. Pateman, A.P. Ijzerman, M. Danhof and A.G. de Boer, Functional role of adenosine receptor subtypes in the regulation of blood–brain barrier permeability: possible implications for the design of synthetic adenosine derivatives (19) 13 ˇ Sentjurc, M., see J. Kristl (19) 181 Shabnam, J., see S.A. Qureshi (19) 291 Singh, S.K., see M. Issar (19) 105 Skiba, M., see H. Marchais (19) 129 Steckel, H. and F. Eskandar, Factors affecting aerosol performance during nebulization with jet and ultrasonic nebulizers (19) 443 Sun, W.Y., see P. Khalili (19) 305 Suri, O.P., see S. Bajad (19) 413 Sutinen, R., see M. Tarvainen (19) 363 Taipale, H., see J. Juntunen (19) 37 Tannergren, C., see H. Engman (19) 57 Tarvainen, M., R. Sutinen, S. Peltonen, H. Mikkonen, J. Maunus, K. ¨ ¨ ¨ V.-P. Lehto and P. Paronen, Enhanced film-forming Vaha-Heikkila, properties for ethyl cellulose and starch acetate using n-alkenyl succinic anhydrides as novel plasticizers (19) 363 ¨ ¨ (19) 223 Taskinen, M., see A. Toyras Teng, C.M., see C.C. Chou (19) 403 Terada, K., see K. Watanabe (19) 91 Tiyaboonchai, W., J. Woiszwillo and C.R. Middaugh, Formulation and characterization of DNA–polyethylenimine–dextran sulfate nanoparticles (19) 191 Tommerup, L., see L. Moesby (19) 245 Toon, S., see R.D. Combes (19) 1 ¨ ¨ ¨ ¨ Tormalehto, S., see H. Monkkonen (19) 23

463

¨ ¨ A., J. Ollikainen, M. Taskinen and J. Monkkonen, ¨ ¨ Toyras, Inhibition of mevalonate pathway is involved in alendronate-induced cell growth inhibition, but not in cytokine secretion from macrophages in vitro (19) 223 Tsai, M.-J., see P.-C. Wu (19) 115 Tsai, Y.-H., see P.-C. Wu (19) 115 ˚ J. Grasjo ´ A., ˚ ¨ and G. Alderborn, Effect of intragranular porosity on Tunon, compression behaviour of and drug release from reservoir pellets (19) 333 ¨ Tuononen, T., see M. Sakkinen (19) 345 ¨ Turpeinen, M., see A. Jappinen (19) 31 ¨ ¨ ¨ K., see M. Tarvainen (19) 363 Vaha-Heikkila, van Tilburg, E.W., see M.P. Schaddelee (19) 13 ¨¨ ¨ ¨ Vepsalainen, J., see H. Monkkonen (19) 23 ¨ Veski, P., see M. Sakkinen (19) 345 Vicini, P., see H. Agersø (19) 141 Victoria, M.M. and C.J. David, Thermal and rheological study of lipophilic ethosuximide suppositories (19) 123 Volk, B., see J. Kristl (19) 181 von Bonsdorff-Nikander, A., M. Karjalainen, J. Rantanen, L. Christiansen and J. Yliruusi, Physical stability of a microcrystalline b-sitosterol suspension in oil (19) 173 Voorwinden, H.L., see M.P. Schaddelee (19) 13 Watanabe, K., K. Terada and J. Sato, Intestinal absorption of cephalexin in diabetes mellitus model rats (19) 91 Wiebe, L.I., see P. Khalili (19) 305 Wilcox, P., see R.D. Combes (19) 1 Woiszwillo, J., see W. Tiyaboonchai (19) 191 Wong, T.W., see P.W.S. Heng (19) 381 Wu, P.-C., Y.-B. Huang, J.-S. Chang, M.-J. Tsai and Y.-H. Tsai, Design and evaluation of sustained release microspheres of potassium chloride prepared by Eudragit  (19) 115 Yes¸im Karasulu, H., see E. Karasulu (19) 99 Yliruusi, J., see A. von Bonsdorff-Nikander (19) 173 Zerrouk, N., see P. Mura (19) 67